Latest news with #NationalMidwivesandNursesDay
The Star
15-05-2025
- Health
- The Star
Govt weighs MMA proposal on medicine displays
PUTRAJAYA: The Health Ministry is contemplating a proposal from the Malaysian Medical Association (MMA) on the implementation of a rule for displaying medicine prices under the Private Healthcare Facilities and Services Act 1998 (Act 586), says Minister Datuk Dr Dzulkefly Ahmad. The proposal, which was included in a memorandum submitted by the MMA, has garnered the attention of Prime Minister Datuk Seri Anwar Ibrahim, who has advised the ministry to conduct a thorough study and evaluation of the proposal. 'The Prime Minister has asked me to carefully review their memorandum, and I have taken this matter seriously. 'I have directed the top leadership of the ministry to look into how we can address the request fairly and consider the feasibility of placing the medicine price display requirement under Act 586, which falls under the ministry's purview,' Dzulkefly told a press conference after attending the 2025 National Midwives and Nurses Day celebration here. He said the ministry is responsive and welcomes constructive suggestions aimed at strengthening the healthcare system. Last Tuesday, MMA urged the government to reassess the application of the Price Control and Anti-Profiteering Act 2011 (Act 723) within the medical sector. This request pertains to the recent regulation that mandates private clinics and pharmacies display the prices of medicines, which began this month. In its memorandum, the MMA expressed its full support for transparency in drug pricing; however, it recommended that this transparency be implemented through Act 586.
The Sun
13-05-2025
- Health
- The Sun
MOH mulls medicine price display under Act 586
PUTRAJAYA: The Ministry of Health (MOH) is considering a proposal from the Malaysian Medical Association (MMA) to implement the Medicine Price Display initiative under the Private Healthcare Facilities and Services Act 1998 (Act 586). Its minister, Datuk Dr Dzulkefly Ahmad said the proposal, which is among the matters raised in a memorandum submitted by the MMA, has received the attention of Prime Minister Datuk Seri Anwar Ibrahim, who has advised the MOH to study and evaluate it. 'The Prime Minister has asked me to carefully review their memorandum, and I have taken this matter seriously. 'I have directed the top leadership of the MOH to look into how we can address the request fairly and consider the feasibility of placing the medicine price display requirement under Act 586, which falls under the ministry's purview,' he told a press conference after attending the 2025 National Midwives and Nurses Day celebration here today. Dr Dzulkefly added that the MOH is committed to being responsive and welcomes constructive suggestions aimed at strengthening the country's healthcare system. On Tuesday, the MMA urged the government to review the use of the Price Control and Anti-Profiteering Act 2011 (Act 723) in the medical sector, particularly with regard to the recent regulation requiring private clinics and pharmacies to display the prices of medicines, which came into effect earlier this month. In its memorandum, the MMA expressed full support for transparency in drug pricing but argued that it should be implemented through Act 586. The regulation on price display, enforced from May 1, is outlined under the Price Control and Anti-Profiteering (Price Marking for Drugs) Order 2025, issued under Act 723. The scope covers all medicines for human use, including controlled medicines, over-the-counter drugs, traditional products, health supplements, and extemporaneous preparations — both prescription and non-prescription. In a related development, Dr Dzulkefly said the MOH is finalising a review of consultation fees for private general practitioners (GPs), which is expected to be presented to the Cabinet by the end of this month. On May 3, Dr Dzulkefly had given an assurance that the review would be concluded within a month.
The Sun
13-05-2025
- Health
- The Sun
MOH to review MMA's proposal on medicine price display under Act 586
PUTRAJAYA: The Ministry of Health (MOH) is considering a proposal from the Malaysian Medical Association (MMA) to implement the Medicine Price Display initiative under the Private Healthcare Facilities and Services Act 1998 (Act 586). Its minister, Datuk Dr Dzulkefly Ahmad said the proposal, which is among the matters raised in a memorandum submitted by the MMA, has received the attention of Prime Minister Datuk Seri Anwar Ibrahim, who has advised the MOH to study and evaluate it. 'The Prime Minister has asked me to carefully review their memorandum, and I have taken this matter seriously. 'I have directed the top leadership of the MOH to look into how we can address the request fairly and consider the feasibility of placing the medicine price display requirement under Act 586, which falls under the ministry's purview,' he told a press conference after attending the 2025 National Midwives and Nurses Day celebration here today. Dr Dzulkefly added that the MOH is committed to being responsive and welcomes constructive suggestions aimed at strengthening the country's healthcare system. On Tuesday, the MMA urged the government to review the use of the Price Control and Anti-Profiteering Act 2011 (Act 723) in the medical sector, particularly with regard to the recent regulation requiring private clinics and pharmacies to display the prices of medicines, which came into effect earlier this month. In its memorandum, the MMA expressed full support for transparency in drug pricing but argued that it should be implemented through Act 586. The regulation on price display, enforced from May 1, is outlined under the Price Control and Anti-Profiteering (Price Marking for Drugs) Order 2025, issued under Act 723. The scope covers all medicines for human use, including controlled medicines, over-the-counter drugs, traditional products, health supplements, and extemporaneous preparations — both prescription and non-prescription. In a related development, Dr Dzulkefly said the MOH is finalising a review of consultation fees for private general practitioners (GPs), which is expected to be presented to the Cabinet by the end of this month. On May 3, Dr Dzulkefly had given an assurance that the review would be concluded within a month.
The Sun
13-05-2025
- Health
- The Sun
MOH forms special committee to tackle vape misuse in schools
PUTRAJAYA: The Ministry of Health (MOH) has set up a special committee to address the misuse of electronic cigarettes or vape, particularly among school students, said Minister Datuk Seri Dr Dzulkefly Ahmad. He said the committee was formed following several viral incidents on social media involving student vape use, as well as cases that led to the deaths of vape users. 'This committee will meet soon and subsequently present its views and recommendations to me,' he told a press conference after attending the 2025 National Midwives and Nurses Day celebration here today. He added that the ministry's Public Health Division (BKA) is currently reviewing the effectiveness of existing enforcement and legislation related to vape misuse. 'The findings and discussions will be presented to the committee, which is chaired by deputy director-general (Public Health) Dr Ismuni Bohari, together with public health consultant Prof Datuk Dr Lokman Hakim Sulaiman,' he said. Dr Dzulkefly said the implementation of the Control of Smoking Products for Public Health Act 2024 (Act 852) was also a key reason behind the formation of the committee to curb vape usage. 'We are currently assessing the impact of existing regulations and conducting surveillance of vape-related cases,' he said. Recently, a 10-second video went viral on social media, showing a group of school students using vape devices in a surau. Another viral video featured an individual claiming to have suffered health complications due to vape addiction before he died last Wednesday.
Barnama
13-05-2025
- Health
- Barnama
MOH To Review MMA's Proposal On Medicine Price Display Under Act 586
GENERAL PUTRAJAYA, May 13 (Bernama) -- The Ministry of Health (MOH) is considering a proposal from the Malaysian Medical Association (MMA) to implement the Medicine Price Display initiative under the Private Healthcare Facilities and Services Act 1998 (Act 586). Its minister, Datuk Dr Dzulkefly Ahmad said the proposal, which is among the matters raised in a memorandum submitted by the MMA, has received the attention of Prime Minister Datuk Seri Anwar Ibrahim, who has advised the MOH to study and evaluate it. 'The Prime Minister has asked me to carefully review their memorandum, and I have taken this matter seriously. 'I have directed the top leadership of the MOH to look into how we can address the request fairly and consider the feasibility of placing the medicine price display requirement under Act 586, which falls under the ministry's purview,' he told a press conference after attending the 2025 National Midwives and Nurses Day celebration here today. Dr Dzulkefly added that the MOH is committed to being responsive and welcomes constructive suggestions aimed at strengthening the country's healthcare system. On Tuesday, the MMA urged the government to review the use of the Price Control and Anti-Profiteering Act 2011 (Act 723) in the medical sector, particularly with regard to the recent regulation requiring private clinics and pharmacies to display the prices of medicines, which came into effect earlier this month. In its memorandum, the MMA expressed full support for transparency in drug pricing but argued that it should be implemented through Act 586. The regulation on price display, enforced from May 1, is outlined under the Price Control and Anti-Profiteering (Price Marking for Drugs) Order 2025, issued under Act 723. The scope covers all medicines for human use, including controlled medicines, over-the-counter drugs, traditional products, health supplements, and extemporaneous preparations — both prescription and non-prescription.
